Form 4 for MTNB Matinas BioPharma Holdings, Inc.
Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-31 · accession 0000905718-22-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | 2021-12-31 | MTNB | WIKLER MATTHEW | Dir | A - Grant | $0.00 | +7,859 | 290.5K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | A | A | 7,859 | $0.00 | 290,472 | D | — | — | (F1) On December 31, 2021, the Reporting Person was issued 7,859 shares of common stock, par value $0.0001 per share, pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant. |